New columns are always added to the right edge of the dataset. Simply click and drag a column by its header to move it. Also, ...
Please provide your email address to receive an email when new articles are posted on . Using data from the 2023-2024 influenza season, researchers determined cell-based influenza vaccines were ...
If you're a fan of the beloved Arizona band The Format and missed out on seeing their mini reunion tour earlier this fall, you're in luck. The indie rock band kicked off their return from a 20-year ...
Researchers at the University of Arkansas and the University of Michigan have reported the first use of ultra-low power temperature sensors using graphene-based solar cells. The test is the first ...
In the fight against cancer, an important field of research is the search for safe alternatives to chemotherapy and radiotherapy. These treatments attack both cancer cells and healthy cells, exposing ...
The brain's mechanisms for repairing injuries caused by trauma or degenerative diseases are not yet known in detail. Now, a study by the University of Barcelona describes a new strategy based on stem ...
Although embryonic stem cells (ESCs) have been successfully derived from mice and rats, efforts to establish chimeric and germline-competent ESC lines in species beyond rodents have been unsuccessful.
Using the updated cheat sheet as our guide, we’ll dive deep into the first round of fantasy drafts. The idea is to help managers navigate Round 1 picks, based on the top-16 rankings for managers in a ...
Despite millions spent on financial software, many finance teams still rely on Excel to close their books and reconcile numbers while preparing them for audit. Two former Microsoft executives view it ...
Paul Thomas Anderson’s One Battle After Another is finally here, and yes, it’s every bit as confounding, ambitious, and star-stuffed as the trailers promised. The action-packed thriller marks the ...
Is there a "right" way to see Paul Thomas Anderson's latest? And, if so, does that mean there's also a "wrong" way? IndieWire's own film obsessives can't agree, but we sure have ideas and arguments to ...